The host response of CD28-deficient mice to Pneumocystis infection.

[1]  J. Shellito,et al.  Immunity against the opportunistic fungal pathogen Pneumocystis. , 2005, Medical mycology.

[2]  S. Kimzey,et al.  T Cell Costimulatory Molecule Function Determines Susceptibility to Infection with Pneumocystis carinii in Mice1 , 2003, The Journal of Immunology.

[3]  M. Qureshi,et al.  IL-10 Modulates Host Responses and Lung Damage Induced by Pneumocystis carinii Infection1 , 2003, The Journal of Immunology.

[4]  J. Shellito,et al.  Local Delivery of the Viral Interleukin-10 Gene Suppresses Tissue Inflammation in Murine Pneumocystis carinii Infection , 2002, Infection and Immunity.

[5]  K. Sepkowitz Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Shellito,et al.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. , 2001, The Journal of clinical investigation.

[7]  J. Finkelstein,et al.  Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. , 1999, The Journal of clinical investigation.

[8]  B. Garvy,et al.  Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection , 1997, Infection and immunity.

[9]  B. Palmer,et al.  Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice. , 1996, The Journal of laboratory and clinical medicine.

[10]  H. Marcotte,et al.  Pneumocystis carinii infection in transgenic B cell-deficient mice. , 1996, The Journal of infectious diseases.

[11]  J. Bluestone,et al.  Absence of B7-dependent responses in CD28-deficient mice. , 1994, Immunity.

[12]  C. Sidman,et al.  Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice , 1993, Infection and immunity.

[13]  J. Curtis,et al.  Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. , 1991, American journal of respiratory cell and molecular biology.

[14]  A. Harmsen,et al.  Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice , 1990, The Journal of experimental medicine.

[15]  L. Shultz,et al.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice , 1989, Infection and immunity.

[16]  W. Hughes,et al.  Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. , 1988, The Journal of clinical investigation.

[17]  S. Kyuwa,et al.  Effect of T-cell transfer on Pneumocystis carinii infection in nude mice. , 1984, The Japanese journal of experimental medicine.

[18]  K. Yoneda,et al.  Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice , 1979, Infection and immunity.

[19]  P. Walzer,et al.  Nude mouse: a new experimental model for Pneumocystis carinii infection. , 1977, Science.

[20]  P. Kvale,et al.  Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. , 1997, American journal of respiratory and critical care medicine.